<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2609222643
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        TRAMAL RETARD 100MG F.C TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        TRAMADOL HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Controlled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        22.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="GRUNENTHAL" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            GRUNENTHAL
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 392]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            AL-KAMAL IMPORT OFFICE CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            STADA ARZNEIMITTEL GmbH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N02AX02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Tramadol &ndash; the active substance in Tramal&reg; retard 100 mg, prolonged-release tablets &ndash; is a centrally acting analgesic painkiller belonging to the class of opioids that acts on the central nervous system.</p><p>It relieves pain by acting on specific nerve cells of the spinal cord and brain.</p><p>Tramal&reg; retard 100 mg, prolonged-release tablets are used for the treatment of moderate</p><p>to severe pain.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; if you are allergic to tramadol or any of the other ingredients of this medicine (listed in section 6).</p><p>&bull; in acute cases of intoxication with alcohol, sleeping pills, painkillers or other psychotropic agents (medicines that affect the mood and emotions)</p><p>&bull; if you are also taking MAO inhibitors (certain antidepressants) or have taken them within the last 14 days before treatment with Tramal&reg; retard 100 mg, prolonged-release tablets (see &ldquo;Other medicines and Tramal&reg; retard 100 mg, prolonged-release tablets&rdquo;)</p><p>&bull; if you suer from epilepsy and this cannot be adequately controlled by treatment</p><p>&bull; as a replacement in drug withdrawal</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking Tramal&reg; retard 100 mg, prolonged-release tablets</p><p>&bull; if you believe that you are dependent on other painkillers (opioids);</p><p>&bull; if your consciousness is impaired (if you feel as if you are going to faint),</p><p>&bull; if you are in a state of shock (cold sweats may be a sign of this),</p><p>&bull; if you have a condition with increased pressure on the brain (possibly after a head injury or brain disease),</p><p>&bull; if you have difficulties in breathing,</p><p>&bull; if you have a tendency towards epilepsy or fits because the risk of a fit may increase;</p><p>&bull; if you have a liver or kidney disorder.</p><p>Epileptic fits have been reported in patients taking tramadol at the recommended dose</p><p>level. The risk may be increased when doses of tramadol exceed the recommended upper</p><p>daily dose limit (400 mg).</p><p>Please note that Tramal&reg; retard 100 mg, prolonged-release tablets may lead to physical</p><p>and psychological addiction. When Tramal&reg; retard 100 mg, prolonged-release tablets are taken for a long time, their effect may decrease, so that higher doses have to be taken (tolerance development).</p><p>In patients with a tendency to abuse medicines or who are dependent on medicines, treatment with Tramal &reg; retard 100 mg, prolonged-release tablets should only be carried out for short periods and under strict medical supervision.</p><p>Please also inform your doctor if one of these problems occurs during Tramal &reg; retard 100 mg, prolonged-release tablets treatment or if they applied to you in the past.</p><p>Tramadol is transformed in the liver by an enzyme. Some people have a variation of this enzyme and this can affect people in different ways. In some people, they may not get enough pain relief but other people are more likely to get serious side effects.</p><p>If you notice any of the following side effects, you must stop taking this medicine and seek immediate medical advice:</p><p>slow or shallow breathing, confusion, sleepiness, small pupils, feeling or being sick, constipation, lack of appetite.</p><p><strong>Other medicines and Tramal&reg; retard 100 mg, prolonged-release tablets</strong></p><p>Tell your doctor or pharmacist if you are taking/using, have recently taken/used or might take/use any other medicines.</p><p>Tramal&reg; retard 100 mg, prolonged-release tablets must not be taken together with MAO inhibitors (certain medicines to treat depression)</p><p>The pain-relieving effect of Tramal&reg; retard 100 mg, prolonged-release tablets may be</p><p>reduced and the length of time it acts may be shortened, if you take medicines which</p><p>contain</p><p>&bull; carbamazepine (for epileptic fits)</p><p>&bull; ondansetron (for nausea)</p><p>Your doctor will tell you whether you can take Tramal&reg; retard 100 mg, prolonged-release tablets and which dose. The risk of side effects increases</p><p>&bull; if you are taking tranquillizers, sleeping pills, other pain relievers such as morphine and codeine (also as cough medicine), and alcohol while you are taking Tramal &reg; retard100 mg, prolonged-release tablets. You may feel drowsier or feel that you might faint. If this happens tell your doctor.</p><p>&bull; if you are taking medicines which may cause convulsions (fits), such as certain antidepressants or antipsychotics. The risk having a fit may increase if you take Tramal &reg; retard 100 mg, prolonged-release tablets at the same time. Your doctor will tell you whether Tramal 100 is suitable for you.</p><p>&bull; if you are taking certain antidepressants, Tramal &reg; retard 100 mg, prolonged-release tablets may interact with these medicines and you may experience symptoms such as involuntary, rhythmic contractions of muscles, including the muscles that control movement of the eye, agitation, excessive sweating, tremor, exaggeration of reflexes, increased muscle tension, body temperature above 38 ˚C.</p><p>&bull; if you are taking coumarin anticoagulants (medicines for blood thinning), e.g. warfarin, together with Tramal &reg; retard 100 mg, prolonged-release tablets. The effect of these medicines on blood clotting may be affected and bleeding may occur.</p><p><strong>Tramal&reg; retard 100 mg, prolonged-release tablets with food and alcohol</strong></p><p>Do not drink alcohol during treatment with Tramal &reg; retard 100 mg, prolonged-release tablets as their effect may be intensified. Food does not influence the effect of Tramal&reg; retard 100 mg, prolonged-release tablets.</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>There is very little information regarding the safety of tramadol in human pregnancy.</p><p>Therefore you should not use Tramal &reg; retard 100 mg, prolonged-release tablets if you are pregnant.</p><p>Chronic use during pregnancy may lead to withdrawal symptoms in newborns.</p><p>Tramadol is excreted into breast milk. For this reason, you should not take Tramal Capsules more than once during breast-feeding, or alternatively, if you take Tramal Capsules more than once, you should stop breast-feeding.</p><p>Generally, the use of tramadol is not recommended during breast-feeding. Small amounts of tramadol are excreted into breast milk. After a single dose it is usually not necessary to interrupt breast-feeding.</p><p>Based on human experience tramadol is suggested not to influence female or male fertility</p><p><strong>Driving and using machines</strong></p><p>Tramal&reg; retard 100 mg, prolonged-release tablets may cause drowsiness, dizziness and blurred vision and therefore may impair your reactions. If you feel that your reactions are affected, do not drive a car or other vehicle, do not use electric tools or operate machinery.</p><p><strong>Tramal&reg; retard 100 mg, prolonged-release tablets contains lactose</strong></p><p>If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. This is because the tablets contain lactose.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>The dosage should be adjusted to the intensity of your pain and your individual pain sensitivity. In general, the lowest pain-relieving dose should be taken. Do not take more than 400 mg tramadol hydrochloride daily, except if your doctor has instructed you to do</p><p>so. Unless otherwise prescribed by your doctor, the usual dose is:</p><p>Adults and adolescents aged 12 years and older</p><p>One Tramal&reg; retard 100 mg prolonged-release tablet twice daily (equivalent to 200 mg tramadol hydrochloride per day), preferably in the morning and evening.</p><p>Your doctor may prescribe a different, more appropriate dosage strength of Tramal prolonged- release tablets if necessary.</p><p>If necessary, the dose may be increased up to 150 mg or 200 mg twice daily (equivalent to 300 mg &ndash; 400 mg tramadol hydrochloride per day).</p><p>Children and adolescents</p><p>Use in children with breathing problems:</p><p>Tramadol is not recommended in children with breathing problems, since the symptoms of tramadol toxicity may be worse in these children.</p><p>Tramal&reg; retard 100 mg, prolonged-release tablets are not intended for use in children under 12 years.</p><p>Elderly patients</p><p>In elderly patients (over 75 years of age), the excretion of tramadol may be delayed. If this affects you, your doctor may recommend prolonging the dosage interval.</p><p>Severe liver or kidney disease (insufficiency)/dialysis patients</p><p>Patients with severe liver and/or kidney insufficiency should not take Tramal &reg; retard 100 mg, prolonged-release tablets. If in your case the insufficiency is mild or moderate, your doctor may recommend prolonging the dosage interval.</p><p>How and when should you take Tramal&reg; retard 100 mg, prolonged-release tablets?</p><p>Tramal&reg; retard 100 mg, prolonged-release tablets are for oral use.</p><p>Always swallow Tramal&reg; retard 100 mg, prolonged-release tablets whole, not divided or chewed, with sufficient liquid, preferably in the morning and evening. You may take the tablets on an empty stomach or with meals.</p><p>How long should you take Tramal&reg; retard 100 mg, prolonged-release tablets?</p><p>You should not take Tramal&reg; retard 100 mg, prolonged-release tablets for longer than</p><p>necessary.</p><p>If you need to be treated for a longer period, your doctor will check at regular short intervals (if necessary with breaks in treatment) whether you should continue to take Tramal&reg; retard 100 mg, prolonged-release tablets and at what dose.</p><p>If you have the impression that the effect of Tramal &reg; retard 100 mg, prolonged-release tablets is too strong or too weak, talk to your doctor or pharmacist.</p><p><strong>If you take more Tramal&reg; retard 100 mg, prolonged-release tablets than you should</strong></p><p>If you have taken an additional dose by mistake, this will generally have no negative effects. You should take your next dose as prescribed.</p><p>After taking very high doses, pin-point pupils, vomiting, fall in blood pressure, fast heart beat, collapse, disturbed consciousness up to coma (deep unconsciousness), epileptic fits, and difficulty in breathing up to cessation of breathing may occur. In such cases a doctor should be called immediately!</p><p><strong>If you forget to take Tramal&reg; retard 100 mg, prolonged-release tablets</strong></p><p>If you have forgotten to take Tramal&reg; retard 100 mg, prolonged-release tablets, your pain may reappear. Do not take a double dose to make up for a forgotten dose. Continue taking your capsules as before.</p><p><strong>If you stop taking Tramal&reg; retard 100 mg, prolonged-release tablets</strong></p><p>If you interrupt or finish treatment with Tramal &reg; retard 100 mg, prolonged-release tablets too soon, pain is likely to return. If you wish to stop treatment on account of unpleasant effects, please tell your doctor.</p><p>You should not suddenly stop taking this medicine unless your doctor tells you to. If you want to stop taking your medicine, discuss this with your doctor first, particularly if you have been taking it for a long time. Your doctor will advise you when and how to stop, which may be by lowering the dose gradually to reduce the chance of developing unnecessary side euects (withdrawal symptoms).</p><p>Generally there will be no after-effects when treatment with Tramal &reg; retard 100 mg, prolonged-release tablets is stopped. However, on rare occasions, people who have been taking Tramal&reg; retard 100 mg, prolonged-release tablets for some time may feel unwell if they abruptly stop taking them. They may feel agitated, anxious, nervous or shaky. They may be hyperactive, have difficulty sleeping and have stomach or bowel disorders. Very few people may get panic attacks, hallucinations, unusual perceptions such as itching, tingling and numbness, and noise in the ears (tinnitus). Further unusual CNS symptoms, i.e. confusion, delusions, change of perception of the own personality (depersonalization), and change in perception of reality (derealisation) and delusion of persecution (paranoia) have been seen very rarely. If you experience any of these complaints after stop taking Tramal &reg; retard 100 mg, prolonged- release tablets, please consult your doctor.</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. You should see a doctor immediately if you experience symptoms of an allergic reaction such as swollen face, tongue and/or throat, and/or difficulty swallowing or hives together with difficulties in breathing.</p><p>The most common side effects during treatment with Tramal&reg; retard 100 mg, prolonged release tablets are nausea and dizziness, which occur in more than 1 in 10 people.</p><p><strong>Very common (more than 1 in 10 patients treated):</strong></p><p>Dizziness, nausea.</p><p><strong>Common (1 to 10 in 100 patients treated):</strong></p><p>Headache, light-headedness, exhaustion, vomiting, constipation, dry mouth, sweating</p><p>(hyperhidrosis).</p><p><strong>Uncommon (1 to 10 in 1,000 patients treated):</strong></p><p>Effect on cardiovascular regulation (palpitations, increased heartbeat [tachycardia], suddenly feeling faint [orthostatic hypotension] or circulatory collapse). In particular, these side effects can occur in the upright position and upon physical exertion.</p><p>Retching, stomach discomfort (e.g. stomach pressure, bloating), diarrhoea.</p><p>Skin reactions (e.g. itching, rash).</p><p><strong>Rare (1 to 10 in 10,000 patients treated):</strong></p><p>Allergic reactions (e.g. difficulty in breathing, wheezing, swelling of skin) and shock (sudden circulation failure) have occurred in very rare cases.</p><p>slow heartbeat</p><p>increase in blood pressure</p><p>abnormal sensations (e.g. itching, tingling, numbness), trembling, epileptic fits, muscle twitches, uncoordinated movement, transient loss of consciousness (syncope), speech disorders.</p><p>Epileptic fits have occurred mainly at high doses of tramadol or when tramadol was taken at the same time as other medicines which may induce fits.</p><p>changes in appetite</p><p>hallucination, confusional state, sleep disorders, delirium, anxiety and nightmares</p><p>Psychological complaints may appear after treatment with Tramal&reg; rapide, 100 mg, tablet.</p><p>Their intensityand nature may vary (according to the patient&rsquo;s personality and length of therapy). These may appear as a change in mood (mostly high spirits, occasionally irritated mood), changes in activity (usually suppression, occasionally increase) and decreased cognitive and sensory perception (changes in senses and recognition, which may lead to errors in judgment).</p><p>Drug dependence may occur.</p><p>vision blurred, constriction of the pupil (miosis), excessive dilation of the pupils (mydriasis) slow breathing, shortness of breath (dyspnoea)</p><p>Worsening of asthma has been reported, however it has not been established whether it was caused by tramadol. If the recommended doses are exceeded, or if other medicines that depress brain function are taken at the same time, breathing may slow down.</p><p>weak muscles</p><p>passing urine with difficulty or pain, passing less urine than normal (dysuria)</p><p><strong>Very rare (less than 1 in 10,000 patients treated):</strong></p><p>Increase in liver enzyme values.</p><p><strong>Not known (frequency cannot be estimated from the available data):</strong></p><p>Decrease in blood sugar levels.</p><p>When treatment is stopped abruptly signs of drug withdrawal syndrome may appear</p><p>(see ‟If you stop taking Tramal&reg; rapide, 100 mg, tablet&rdquo;)</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</p><p>By reporting side effects you can help provide more information on the safety of this medicine.</p><p><strong>To report adverse events:</strong></p><p><strong>&bull; Saudi Arabia:</strong></p><p>The National Pharmacovigilance and Drug Safety Centre (NPC). SFDA</p><p>- Fax: +966-11-205-7662</p><p>- Call NPC at +966-11-20382222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>-Toll free phone: 8002490000</p><p>- E-mail: npc.drug@sfda.gov.sa</p><p>- Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p><p><strong>Other GCC States:</strong></p><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the carton and the blister. The expiry date refers to the last day of that month. Do not store above 30 ˚C.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is: tramadol hydrochloride.</p><p>Tramal&reg; retard 100 mg, prolonged-release tablets:</p><p>Each tablet contains 100 mg tramadol hydrochloride.</p><p>The other ingredients are:</p><p>Tablet core: microcrystalline cellulose, hypromellose 100 000 mPa&middot;s, magnesium stearate, colloidal anhydrous silica.</p><p>Film coating: hypromellose 6 mPa&middot;s, lactose monohydrate (see section 2 &ldquo;Tramal &reg; retard 100 mg, prolonged-release tablets contains lactose&rdquo;), macrogol 6000, propylene glycol, talc, titanium dioxide (E 171).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Tramal® retard 100 mg, prolonged-release tablets are round, biconvex white coloured
film-coated tablets, marked with the logo on one side, marked T1 on the other side.
Tramal® retard 100 mg, prolonged-release tablets are packed in blister strips and are
supplied in boxes of 10, 20, 30, 50, 60, 100 and 150 (10x15) tablets. Not all pack sizes
may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>STADA Arzneimittel AG</p><p>Stadastrasse 2-18</p><p>61118 Bad Vilbel</p><p>Germany</p><p>Bulk Manufacturer</p><p>Farmaceutici Formenti S.p.A.</p><p>Via di Vittorio 2</p><p>21040 Origgio (VA)</p><p>Italy</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Date of last revision is March, 2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ترامادول - المادة الفعالة في أقراص ترامال 100مجم الممتدة الانطلاق- هو مسکن يعمل مركزيًا ينتمي إلى مجموعة المواد الأفيانية. يحقق تأثيره المخفف للألم عن طريق العمل على خلايا عصبية معينة في الحبل الشوكي والدماغ.</p><p dir="RTL">يستخدم أقراص ترامال 100مجم الممتدة الانطلاق العلاج الألم متوسط الشدة إلى الشديد</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تأخذ أقراص ترامال 100مجم الممتدة الانطلاق</strong></p><p dir="RTL">- إذا كنت تعاني من حساسية (أو فرط حساسية تجاه ترامادول أو تجاه أي من مكونات أقراص ترامال 100مجم الممتدة الانطلاق المذكورة في البند 6</p><p dir="RTL">- في حالات التسمم الحادة بالكحول، الأقراص المنومة، المسكنات أو غيرها من المواد نفسية الانتحاء</p><p dir="RTL">الأدوية التي تؤثر على الحالة المزاجية والمشاعر)</p><p dir="RTL">- إذا كنت تأخذ أيضا مثبطات اکسيديز أحادي الأمين (مضادات اكتئاب معينة أو قمت بأخذها خلال</p><p dir="RTL">الى 14 يوم الأخيرة قبل العلاج باستخدام أقراص ترامال 100مجم الممتدة الانطلاق (انظر &quot;الأدوية الأخرى وأقراص ترامال 100مجم الممتدة الانطلاق).</p><p dir="RTL">- إذا كنت تعاني من الصرع ولا يمكن السيطرة على الحالة بشكل كافي مع العلاج</p><p dir="RTL">- كبديل في حالات الانسحاب من المخدرات</p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL"><strong>تحدث مع طبيبك الخاص او الصيدلي قبل أخذ أقراص ترامال 100مجم الممتدة الانطلاق</strong></p><p dir="RTL">- إذا كنت تعتقد بأنك ربما تكون معتمد على مسكنات أخري (أفيانيات)</p><p dir="RTL">- إذا كنت في حالة صدمة (العرق البارد قد يكون إحدى العلامات) ؛</p><p dir="RTL">- إذا كنت تعاني من زيادة الضغط في المخ (على الأرجح عقب إصابة في الرأس أو مرض بالمخ) ؛</p><p dir="RTL">- إن كنت تعاني من صعوبة بالتنفس؛</p><p dir="RTL">- إن كنت عرضة للإصابة بالصرف أو التشنجات وذلك لأن خطر الإصابة بالتشنجات قد يرتفع؛</p><p dir="RTL">- إن كنت تعاني من اضطراب بالكبد أو الكلى؛</p><p dir="RTL">تم الإبلاغ عن حدوث نوبات صرع في المرضى الذين يأخذون ترامادول عند مستوى الجرعة الموصي بها. قد يرتفع الخطر عند تجاوز جرعات ترامادول الحد الأعلى للجرعة اليومية الموصي بها (400 مجم)</p><p dir="RTL">يرجى ملاحظة إن أقراص ترامال 100مجم الممتدة الانطلاق يمكن أن تؤدي لإدمان نفسي وجسدي.</p><p dir="RTL">عند استخدام أقراص ترامال 100مجم الممتدة الانطلاق لفترة زمنية طويلة، قد تقل فاعليتها، لذلك يلزم أخذ جرعات أعلى (حدوث حالة التحمل).</p><p dir="RTL">بالنسبة للمرضى الذين لديهم ميل لسوء استخدام الأدوية أو المعتمدين على الأدوية، العلاج باستخدام أقراص ترامال 100مجم الممتدة الانطلاق ينبغي أن يكون لمدة قصيرة فقط ويتم تحت الإشراف الدقيق من جانب الطبيب.</p><p dir="RTL">كذلك، يرجى إبلاغ طبيبك الخاص في حالة حدوث أي من هذه المشاكل أثناء أخذك ل لأقراص ترامال 100مجم الممتدة الانطلاق، أو إذا كان قد سبق وانطبقت عليك في أي وقت مضى.</p><p dir="RTL">يتحول الترامادول في الكبد بفعل إنزيم معين. وبعض الأشخاص يكون لديهم شكل مختلف من هذا الإنزيم، وهو ما يمكن أ، يؤدي إلى آثار مختلفة للدواء. ففي بعض الأحيان، قد لا يشعر المريض براحة كافية؛ بل إن بعض الأشخاص قد يصابون بأعراض جانبية خطيرة.</p><p dir="RTL">فإذا لاحظت أيًا من الأعراض الجانبية التالية، فيجب عليك التوقف عن تناول هذا الدواء وطلب الاستشارة الطبية على الفور:</p><p dir="RTL">بطء أو سرعة التنفس، التشوش، النعاس، شغر بؤبؤ العين، الشعور أو الإصابة بالإعياء، الإمساك، فقدان الشهية.</p><p dir="RTL"><strong>الأدوية الأخرى وأقراص ترامال 100مجم الممتدة الانطلاق </strong></p><p dir="RTL">أبلغ طبيبك الخاص أو الصيدلي إذا كنت تأخذ، أو قمت مؤخرا بأخذ أو ربما أخذت أي أدوية أخرى. لا ينبغي أخذ أقراص ترامال 100مجم الممتدة الانطلاق بالاشتراك مع مثبطات اوكسيديز أحادي الأمين (أدوية معينة لعلاج الاكتئاب).</p><p dir="RTL">ربما ينخفض التأثير المخفف للألم الخاص بأقراص ترامال 100مجم الممتدة الانطلاق وقد يقصر زمن مفعولها إذا كنت تأخذ الأدوية التي تحتوي على:</p><p dir="RTL">&bull; كاربامازيبين (لنوبات الصرع) ؛</p><p dir="RTL">&bull; أوندانسيترون (للغثيان)؛</p><p dir="RTL">سوف يخبرك طبيبك ما إن كان يمكنك أن تأخذ أقراص ترامال 100مجم الممتدة الانطلاق ويحدد</p><p dir="RTL">لك الجرعة.</p><p dir="RTL">خطر الآثار الجانبية يزيد،</p><p dir="RTL">-&nbsp; إذا كنت تأخذ مهدئات، حبوب منومة، بعض المسكنات الأخرى مثل المورفين والكودايين (أيضا عند استخدامه كدواء للسعال) ، وكذلك الكحول مع استخدامك لأقراص ترامال 100مجم الممتدة الانطلاق. قد تشعر بالنعاس أو أنك على وشك الإغماء. إذا حدث ذلك أبلغ طبيبك الخاص.</p><p dir="RTL">- إذا كنت تأخذ الأدوية التي يمكن أن تسبب حدوث نوبات (تشنجات)، مثل بعض مضادات</p><p dir="RTL">الاكتئاب أو مضادات الذهان. قد يرتفع خطر حدوث التشنجات إذا كنت تأخذ أقراص ترامال 100 مجم الممتدة الانطلاق في نفس الوقت. سوف يخبرك الطبيب ما إن كان ترامال 100مجم مناسب لك أم لا.</p><p dir="RTL">- إذا كنت تأخذ بعض مضادات الاكتئاب. أقراص ترامال 100مجم الممتدة الانطلاق قد تتفاعل مع</p><p dir="RTL">هذه الأدوية وربما تشعر بأعراض مثل الانقباض العضلي الايقاعي اللاارادي، ويشمل العضلات التي</p><p dir="RTL">تتحكم بحركة العين، هياج، فرط التعرق، رعشة، فرط المنعكسات، زيادة توتر العضلات، وارتفاع</p><p dir="RTL">درجة حرارة الجسم لأعلى من ˚ 38م.</p><p dir="RTL">- إذا كنت تأخذ مضادات التجلط من نوع الكومارين (أدوية لسيولة الدم) ، مثل: وارفارين، في</p><p dir="RTL">نفس الوقت مع أقراص ترامال 100مجم الممتدة الانطلاق. قد يتأثر مفعول هذه الأدوية على</p><p dir="RTL">التجلط ويمكن أن يحدث نزيف.</p><p dir="RTL"><strong>أقراص ترامال 100مجم الممتدة الانطلاق مع الطعام والكحول</strong></p><p dir="RTL">لا تشرب الكحول أثناء العلاج باستخدام أقراص ترامال 100مجم الممتدة الانطلاق وذلك لأن تأثيرها</p><p dir="RTL">قد يشتد. الطعام لا يؤثر على فاعلية أقراص ترامال 100مجم الممتدة الانطلاق.</p><p dir="RTL"><strong>الحمل، والرضاعة، والخصوبة</strong></p><p dir="RTL">إذا كنت ِ حاملاً أو ترضعين، أو إذا كنت ِ تظنين إنك ربما تكونين حاملاً أو تخططين لإنجاب طفل،</p><p dir="RTL">اطلبي مشورة طبيبك الخاص أو الصيدلي قبل أخذ هذا الدواء.</p><p dir="RTL">تتوفر معلومات بسيطة فقط بخصوص أمان استخدام ترامادول في الحمل. لذلك لا ينبغي عليك أخذ أقراص ترامال 100مجم الممتدة الانطلاق إذا كنت حاملاً.</p><p dir="RTL">الاستخدام المزمن خلال فترة الحمل يمكن أن يؤدي لظهور أعراض الانسحاب على حديثي الولادة.</p><p dir="RTL">يتم إفراز الترامادول في حليب الثدي. ولهذا السبب، يجب عليك عدم تناول كبسولات ترامال أكثر من مرة واحدة خلال فترة الرضاعة الطبيعية، أو التوقف عن الرضاعة الطبيعية عند تناول كبسولات ترامال أكثر من مرة.</p><p dir="RTL">لا يوصى باستخدام الترامادول أثناء الرضاعة بصفة عامة. يتم إفراز الترامادول بكميات بسيطة في لبن الأم. لا داعي عادةً لوقف الرضاعة بعد تناول جرعة واحدة.</p><p dir="RTL">بناء على الخبرة المستمدة من الاستخدام في الإنسان، من المفترض أن ترامادول لا يؤثر على خصوبة الذكور أو الإناث.</p><p dir="RTL"><strong>القيادة والقدرة على استخدام الألات</strong></p><p dir="RTL">استخدام أقراص ترامال 100مجم الممتدة الانطلاق قد يؤدي للشعور بالنعاس، الدوخة، وغشاوة الإبصار وبالتالي ربما يؤثر على ردود أفعالك. إذا كنت تشعر بتأثر ردود أفعالك، لا تقم بقيادة السيارة أو أي مركبة أخرى، ولا تقم باستخدام أي أدوات كهربائية أو تشغيل الآلات.</p><p dir="RTL">أقراص ترامال 100مجم الممتدة الانطلاق تحتوي على لاكتوز</p><p dir="RTL">إذا أبلغك طبيبك الخاص بعدم قدرتك على تحمل بعض السكريات، اتصل بطبيبك قبل أخذ هذا المستحضر الطبي. وذلك لأن الأقراص تحتوي على اللاكتوز.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">خذ دائمًا هذا الدواء تماما كما وصف لك طبيبك. تأكد من طبيبك الخاص أو الصيدلي إذا كنت غير متأكد.</p><p dir="RTL">ينبغي تعديل الجرعة حسب شدة الألم الذي تشعر به وحسب حساسيتك الشخصية للألم. بصفة عامة، ينبغي اختيار أقل جرعة مخففة للألم. لا تأخذ أكثر من 400مجم من هيدروكلوريد الترامادول يوميًا، إلا إذا نصحك الطبيب بذلك.</p><p dir="RTL">ما لم ينص على خلاف ذلك من قبل الطبيب، فالجرعة المعتادة هي:</p><p dir="RTL">البالغون والمراهقون من عمر 12سنة</p><p dir="RTL">قرص واحد من أقراص ترامال 100مجم الممتدة الانطلاق مرتين يوميًا (ما يعادل 200مجم من هيدروكلوريد الترمادول في اليوم)، يفضل صباح ً ا ومساءًا.</p><p dir="RTL">قد يصف لك الطبيب تركيز مختلف أكثر ملائمة من أقراص ترامال الممتدة الانطلاق إذا لزم الأمر. إن كان ضروري، يمكن زيادة الجرعة حتى تصل إلى 150مجم أو 200مجم مرتين يوميًا (ما يعادل 300مجم &ndash; 400مجم من هيدروكلوريد الترامادول في اليوم).</p><p dir="RTL">الأطفال والمراهقون</p><p dir="RTL">الاستخدام مع الأطفال الذين يعانون من صعوبات في التنفس:</p><p dir="RTL">لا يوصى باستخدام الترامادول مع الأطفال الذين يعانون من صعوبات في التنفس، حيث إن أعراض التسمم بالترامادول قد تكون أكثر خطورة لدى هؤلاء الأطفال.</p><p dir="RTL">أقراص ترامال 100مجم الممتدة الانطلاق غير مناسبة للأطفال دون سن 12سنة.</p><p dir="RTL">المرضى المسنون</p><p dir="RTL">في المرضى المسنين (أكثر من 75سنة من العمر)، قد يتأخر إخراج الترامادول. إذا كان هذا الأمر ينطبق عليك، قد يوصي طبيبك بتمديد الفترات الفاصلة بين الجرعات.</p><p dir="RTL">مرض حاد بالكبد أو الكلى (قصور)/ المرضى الذين يخضعون لغسيل الكلى</p><p dir="RTL">المرضى الذين يعانون من قصور حاد بالكبد و/أو الكلى لا ينبغي عليهم أخذ أقراص ترامال 100 مجم الممتدة الانطلاق. إذا كان القصور في حالتك يعتبر خفيف أو متوسط، قد يوصي طبيبك بتمديد الفترات الفاصلة بين الجرعات.</p><p dir="RTL">كيف ومتى يجب أن تأخذ أقراص ترامال 100مجم الممتدة الانطلاق؟</p><p dir="RTL">أقراص ترامال 100مجم الممتدة الانطلاق مخصصة للاستخدام عن طريق الفم.</p><p dir="RTL">قم دائمًا ببلع أقراص ترامال 100مجم الممتدة الانطلاق بالكامل، لا تقسم ولا تمضغ، مع كمية كافية من السوائل، يفضل صباحًا ومساءًا. يمكن أن تأخذ الأقراص على معدة فارغة أو مع وجبات الطعام.</p><p dir="RTL">ما هي المدة التي يجب أن تؤخذ فيها أقراص ترامال 100مجم الممتدة الانطلاق؟</p><p dir="RTL">لا تأخذ أقراص ترامال 100مجم الممتدة الانطلاق لفترة أطول مما هو ضروري.</p><p dir="RTL">إذا كنت محتاج للعلاج لفترة أطول، سوف يقوم طبيبك بالمتابعة بانتظام على فترات قصيرة (إذا لزم الأمر، مع فترات راحة من العلاج) ويرى ما إن كان يلزم مواصلة أخذ أقراص ترامال 100مجم الممتدة الانطلاق ويحدد الجرعة.</p><p dir="RTL">إذا كان لديك انطباع أن تأثير أقراص ترامال 100مجم الممتدة الانطلاق قوي جد ً ا أو ضعيف جدًا، يرجى التحدث إلى طبيبك الخاص أو الصيدلي.</p><p dir="RTL"><strong>إذا أخذت أقراص ترامال 100مجم الممتدة الانطلاق أكثر مما يجب</strong></p><p dir="RTL">إذا أخذت عن طريق الخطأ جرعة إضافية، لن يكون لذلك بصفة عامة أي آثار سلبية. خذ الجرعة</p><p dir="RTL">التالية كما هو مقرر.</p><p dir="RTL">بعد أخذ جرعات عالية للغاية، قد يحدث ما يلي: تضيق حدقة العين، تقيؤ، انخفاض في ضغط الدم،</p><p dir="RTL">سرعة ضربات القلب، انهيار، اضطراب الوعي وقد يصل الأمر للغيبوبة (فقدان الوعي العميق)،</p><p dir="RTL">تشنجات صرعية وصعوبة في التنفس أو حتى توقف التنفس. في هذه الحالات، ينبغي الاتصال</p><p dir="RTL">بالطبيب على الفور!</p><p dir="RTL"><strong>إذا نسيت أن تأخذ أقراص ترامال 100مجم الممتدة الانطلاق</strong></p><p dir="RTL">إذا نسيت أن تأخذ الأقراص، من المرجح أن يعود الألم. لا تأخذ جرعة مضاعفة لتعويض الجرعات</p><p dir="RTL">الفردية المنسية، استمر ببساطة في أخذ الأقراص الخاصة بك كما كان من قبل.</p><p dir="RTL"><strong>إذا توقفت عن تناول بأقراص ترامال 100مجم الممتدة الانطلاق</strong></p><p dir="RTL">إذا قطعت أو أوقفت العلاج بأقراص ترامال 100مجم الممتدة الانطلاق سريعًا جدًا، ربما يتسبب ذلك في ظهور الأم مرة أخرى. إذا كنت ترغب في التوقف عن العلاج بسبب الآثار الجانبية المزعجة، يرجى الاتصال بالطبيب.</p><p dir="RTL">يجب عدم التوقف بشكل مفاجئ عن تناول هذا الدواء ما لم يكن ذلك بناء على أمر الطبيب. فإذا أردت التوقف عن تناول الدواء، ناقش الأمر مع طبيبك أولا، وخاصة إذا كنت بدأت تناوله منذ فترة طويلة. سوف يخبرك الطبيب بسبب وكيفية التوقف عن تناول الدواء، ويمكن أن يتم ذلك من خلال خفض الجرعة بالتدريج للحد من الآثار الجانبية المصاحبة (أعراض الانسحاب).</p><p dir="RTL">بشكل عام، وقف العلاج بأقراص ترامال 100مجم الممتدة الانطلاق لن يكون له أي آثار لاحقة. ومع ذلك، في حالات نادرة، الأشخاص الذين يأخذون أقراص ترامال 100مجم الممتدة الانطلاق لبعض الوقت قد يشعروا بالتوعك عند التوقف فجأة عن أخذها. ربما يشعروا بالهياج، القلق، العصبية أو الرعشة. ربما يتعرضوا لفرط النشاط أو اضطرابات النوم أو اضطرابات بالمعدة أو الأمعاء. وهناك ً عدد قليل جدا من الناس ربما تحدث لهم نوبات هلع، هلوسة، تصورات غير معتادة مثل حكة، ً وخز، وتنميل، وضجيج في الأذنين (طنين). لوحظت أيض ً ا في حالات نادرة جدا أعراض غير معتادة أخرى بالجهاز العصبي المركزي، مثل الارتباك، الأوهام، تغير في إدراك الشخصية (تبدد الشخصية) وتغير في إدراك الحقيقة (الانفصال عن الواقع) وهوس الاضطهاد (البارانويا). إذا شعرت بأي من هذه الآثار بعد وقف العلاج مع أقراص ترامال 100مجم الممتدة الانطلاق، يرجى الاتصال بالطبيب. إذا كان لديك أي أسئلة أخرى عن استخدام هذا الدواء، أسأل طبيبك الخاص أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شأنه شأن جميع الأدوية، قد يتسبب هذا الدواء في حدوث أثار جانبية، على الرغم من عدم تعرض الجميع لها.</p><p dir="RTL"><strong>يجب عليك استشارة طبيبك على الفور إذا لاحظت أي علامات على الإصابة برد فعل تحسي، مثل تورم الوجه و/أو اللسان و/أو الحلق، و/أو صعوبات في البلع، أو طفح فراصي مصحوب بمشاكل في التنفس.</strong></p><p dir="RTL">أكثر الأثار الجانبية شيوعًا والتي تحدث أثناء العلاج باستخدام ترامال ۱۰۰ مجم الممتدة الانطلاق هي الغثيان والدوار، وتحدث في أكثر من مريض واحد من كل ۱۰ مرضى يتم علاجهم.</p><p dir="RTL"><strong>شائعة جدًا (تؤثر على أكثر من مريض واحد من كل </strong><strong>۱۰</strong><strong> مرضي يتم علاجهم):</strong></p><p dir="RTL">دوار، غثيان،</p><p dir="RTL"><strong>شائعة (تؤثر على مريض واحد إلى 10 مرضى من كل </strong><strong>۱۰۰</strong><strong> مريض يتم علاجهم):</strong></p><p dir="RTL">صداع، دوخة، إرهاق، فيه، إمساك، جفاف الفم، تعرق (فرط التعرق)</p><p dir="RTL"><strong>غير شائعة (تؤثر على مريض واحد إلى 10 مرضى من كل </strong><strong>۱۰۰۰</strong><strong> مريض يتم علاجهم):</strong></p><p dir="RTL">تأثير على نظم القلب والأوعية الدموية (خفقان، زيادة نبض القلب (تسارع نبض القلب)، شعور مفاجئ بالإغماء أو هبوط ضغط الدم الانتصابي (هبوط الدورة الدموية). تحدث هذه الآثار بشكل خاص لدى المرضى في وضع الوقوف وبعد التعرض لإجهاد جسدي.</p><p dir="RTL">رغبة في القيء (تهوع)، مشاكل في المعدة (مثلاً: ضغط المعدة والانتفاخ)، إسهال.</p><p dir="RTL">حساسية جلدية (مثلاً: حكة أو طفح جلدي).</p><p dir="RTL"><strong>نادرة (تؤثر على مريض واحد إلى 10 مرضى من كل ...</strong><strong>۱۰</strong><strong> مريض يتم علاجهم):</strong></p><p dir="RTL">حدثت تفاعلات تحسسية (مثلًا: ضيق التنفس، أصوات صرير عند التنفس (غطيط صفيري)، أو تجمع ماء في الأنسجة (وذمة وعائية)، أو تفاعلات صدمية (هبوط مفاجئ في الدورة الدموية)، في حالات نادرة جدا.</p><p dir="RTL">تباطؤ في نبض القلب،</p><p dir="RTL">ارتفاع في ضغط الدم</p><p dir="RTL">تغيرات في الشهية.</p><p dir="RTL">هلوسة وحالة من الارتباك واضطرابات في النوم وهذيان وقلق وكوابيس.</p><p dir="RTL">قد تحدث أعراض نفسية بعد العلاج باستخدام أقراص ترامال 100مج، وقد تختلف في شدتها وطبيعتها بشكل فردي (بناء على شخصية المريض ومدة الاستخدام).</p><p dir="RTL">وقد تشمل تغيرات في الحالة المزاجية (غالبًا شعور بالابتهاج)، وأحيانًا شعور بالضيق)، تغيرات في النشاط (غالبًا ما يكون تثبيطًا، وأحيانًا فرط في النشاط)، ونقص في قدرة الشخص على فهم أفكاره ومشاعره، مما قد يؤدي إلى أخطاء في اتخاذ القرارات (ضعف الأداء الحسي والمعرفي).</p><p dir="RTL">قد يحدث إدمانًا للدواء.</p><p dir="RTL">تغيم في الرؤية، ضيق في حدقة العين (تقبض الحدقة)، اتساع شديد في حدقة العين (توسع الحدقة) تباطؤ التنفس، وضيق التنفس.</p><p dir="RTL">أَبلغ عن تفاقهم حالات الربو، على الرغم من عدم اكتشاف ما إذا كان السبب هو الترامادول.</p><p dir="RTL">إذا تم تجاوز الجرعة الموصي بها، أو إذا تعاطي المريض أدوية أخرى ذات آثار مثبطة لوظائف المخ، قد يحدث تباطؤ في التنفس.</p><p dir="RTL">ضعف عضلي</p><p dir="RTL">صعوبة أو ألم أثناء التبول، أو إخراج كميات بول أقل من المعتاد (اضطرابات التبول وعسر البول)</p><p dir="RTL"><strong>نادرة جدا (تؤثر على أقل من مريض واحد من كل </strong><strong>۱۰۰۰۰</strong><strong> مريض يتم علاجهم):</strong></p><p dir="RTL">زيادة في قيم وظائف الكبد</p><p dir="RTL"><strong>غير معروفة (لا يمكن تقديرها من خلال البيانات المتاحة):</strong></p><p dir="RTL">انخفاض في مستويات سكر الدم.</p><p dir="RTL"><strong>التبليغ عن الآثار الجانبية</strong></p><p dir="RTL">تحدث مع طبيبك أو الصيدلي إذا تعرضت لأية آثار جانبية، ويشمل ذلك أي آثار جانبية محتملة غير مذكورة في هذه النشرة.</p><p dir="RTL">عن طريق التبليغ عن الآثار الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول أمن وسلامة هذا الدواء.</p><p dir="RTL"><strong>للتبليغ عن الآثار السلبية:</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية:</strong></p><p dir="RTL">المركز القومي للتيقظ والسلامة الدوائية. (الهيئة العامة للغذاء والدواء)</p><p dir="RTL">فاكس: 7662-205-11-966+</p><p dir="RTL">اتصل بمركز التيقظ الدوائي على رقم: 20382222-11-966+</p><p dir="RTL">تحويلة 2317 &ndash; 2356 &ndash; 2353 &ndash; 2254 &ndash; 2334 &ndash; 2340</p><p dir="RTL">الرقم المجاني: 8002490000</p><p dir="RTL">بريد إلكترونيnpc.drug@sfda.gov.sa:</p><p dir="RTL">موقع إلكتروني: www.sfda.gov.sa/npc</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول مجلس التعاون الخليجي الأخرى:</strong></p><p dir="RTL">يرجي التواصل مع الجهات المعنية ذات الصلة</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحفظ بعيدا عن متناول ومرأى الأطفال.</p><p dir="RTL">لا تستخدم هذا الدواء بعد انتهاء تاريخ الصلاحية المذكور على العلبة الخارجية والشريط.</p><p dir="RTL">تاريخ الصلاحية يشير إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">يخزن في درجة حرارة لا تتجاوز ˚ 30م.</p><p dir="RTL">لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. أسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدم. سوف تساعد هذه التدابير في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي: هيدروكلوريد الترامادول</p><p dir="RTL">أقراص ترامال 100مجم الممتدة الانطلاق:</p><p dir="RTL">كل قرص يحتوي على 100مجم من هيدروكلوريد الترامادول.</p><p dir="RTL">المكونات الأخرى هي:</p><p dir="RTL">لُب القرص: سلليولوز دقيق البللورات، هيبروميللوز 100000وحدة، ستياريت الماغنسيوم سيليكا غروانية لا مائية.</p><p dir="RTL">الغلاف:</p><p dir="RTL">هيبروميللوز 6وحدات، لاكتوز أحادي الهيدرات (انظر البند &laquo;2أقراص ترامال 100مجم الممتدة</p><p dir="RTL">الانطلاق تحتوي على لاكتوز&raquo;)، ماكروجول ،6000بروبيلين جلايكول، تلك، ثاني أكسيد التيتانيوم (أي 171)<strong> </strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أقراص ترامال 100مجم الممتدة الانطلاق هي عبارة عن أقراص مغلفة مستديرة، ثنائية التحدب، ولونها أبيض، موسومة بشعار الشركة المصنعة على جانب واحد، و 1Tعلى الجانب الآخر.</p><p dir="RTL">أقراص ترامال&nbsp; 100مجم الممتدة الانطلاق معبأة في شرائط ومتوفرة في علب من 10، 20، 30، 50، 60، 100، 150 (10 &times; 15) قرص</p><p dir="RTL">قد لا يتم تسويق جميع أحجام العبوة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ستادا أرزنیمینال آج</p><p dir="RTL">ستادا شتراسيه 2-18</p><p dir="RTL">61118باد فيلبل</p><p dir="RTL">ألمانيا</p><p dir="RTL">المصنع: بلك:</p><p dir="RTL">فارماسيوتي فورمنتي</p><p dir="RTL">فيا دي فيتوريو 2</p><p dir="RTL">21040 اوريجيو</p><p dir="RTL">ايطاليا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تاريخ آخر مراجعة: مارس ۲۰۱۸
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                100 mg prolonged-release tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active substance: tramadol hydrochloride


< Tramal retard > 100 mg prolonged-release tablets
1 prolonged-release tablet contains 100 mg tramadol hydrochloride.
<Tramal retard > 150 mg prolonged-release tablets
1 prolonged-release tablet contains 150 mg tramadol hydrochloride.
< Tramal retard > 200 mg prolonged-release tablets
1 prolonged-release tablet contains 200 mg tramadol hydrochloride.

Excipient with known effect: Each prolonged-release tablet contains 2.5 mg lactose monohydrate (see section 4.4).

For the full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Prolonged-release tablet

round, biconvex, film-coated tablets, marked with the manufacturer‘s logo on one side

-	50 mg tablet: pale yellow coloured, marked T0 on the other side
-	100 mg tablet: white coloured, marked T1 on the other side
-	150 mg tablet: pale orange coloured, marked T2 on the other side
-	200 mg tablet: slightly brownish orange coloured, marked T3 on the other side

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment of moderate to severe pain</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>&nbsp;</p><p>The dose should be adjusted to the intensity of the pain and the sensitivity of the individual patient. The lowest effective dose for analgesia should generally be selected. Daily doses of 400 mg tramadol hydrochloride should not be exceeded, except in special clinical circumstances.</p><p>&nbsp;</p><p>Unless otherwise prescribed, &lt; Tramal retard &gt; should be administered as follows:</p><p>&nbsp;</p><p>&nbsp;</p><p><em>Adults and adolescents above the age of 12 years</em></p><p><em>&nbsp;</em></p><p>The usual initial dose is 50-100 mg tramadol hydrochloride twice daily, morning and evening. If pain relief is insufficient, the dose may be titrated upwards to 150 mg or 200 mg tramadol hydrochloride twice daily (see section 5.1).</p><p>&nbsp;</p><p>&lt; Tramal retard &gt; should under no circumstances be administered for longer than absolutely necessary. If long-term pain treatment with &lt; Tramal retard &gt; is necessary in view of the nature and severity of the illness, then careful and regular monitoring should be carried out (if necessary with breaks in treatment) to establish whether and to what extent further treatment is necessary.</p><p>&nbsp;</p><p><em>Paediatric</em><em> </em><em>population</em></p><p><em>&nbsp;</em></p><p>&lt; Tramal retard &gt; is not suitable for children below the age of 12 years.</p><p>&nbsp;</p><p><em>Older people</em></p><p><em>&nbsp;</em></p><p>A dose adjustment is not usually necessary in patients up to 75 years without clinically manifest hepatic or renal insufficiency. In older people over 75 years elimination may be prolonged. Therefore, if necessary the dosage interval is to be extended according to the patient&rsquo;s requirements.</p><p>&nbsp;</p><p><em>Patients</em><em> </em><em>with</em><em> </em><em>renal insufficiency/dialysis and hepatic impairment</em></p><p><em>&nbsp;</em></p><p>In patients with renal and/or hepatic insufficiency the elimination of tramadol is delayed. In these patients prolongation of the dosage intervals should be carefully considered according to the patient&rsquo;s requirements. In cases of severe renal and/or severe hepatic insufficiency &lt; Tramal retard &gt; prolonged-release tablets are not recommended.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>&nbsp;</p><p>The tablets are to be taken whole, not divided or chewed, with sufficient liquid, independent of meals.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                < Tramal retard > is contraindicated
-	in hypersensitivity to the active substance or any of the excipients listed in section 6.1,
-	in acute intoxication with alcohol, hypnotics, analgesics, opioids or other psychotropic medicinal products,
-	in patients who are receiving MAO inhibitors or who have taken them within the last 14 days (see section 4.5),
-	in patients with epilepsy not adequately controlled by treatment,
-	for use in narcotic withdrawal treatment.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&lt; Tramal retard &gt; may only be used with particular caution in opioid-dependent patients, patients with head injury, shock, a reduced level of consciousness of uncertain origin, disorders of the respiratory center or function, increased intracranial pressure.</p><p>&nbsp;</p><p>In patients sensitive to opiates &lt; Tramal retard &gt; should only be used with caution.</p><p>&nbsp;</p><p>Care should be taken when treating patients with respiratory depression, or if concomitant CNS depressant drugs are being administered (see section 4.5), or if the recommended dosage is significantly exceeded (see section 4.9) as the possibility of respiratory depression cannot be excluded in these situations.</p><p>&nbsp;</p><p>&nbsp;</p><p>Convulsions have been reported in patients receiving tramadol at the recommended dose levels. The risk may be increased when doses of tramadol hydrochloride exceed the recommended upper daily dose limit (400 mg). In addition, tramadol may increase the seizure risk in patients taking other medicinal products that lowers the seizure threshold (see section 4.5). Patients with epilepsy or those susceptible to seizures should only be treated with tramadol if there are compelling circumstances.</p><p>&nbsp;</p><p>Tolerance, psychic and physical dependence may develop, especially after long-term use. In patients with a tendency to drug abuse or dependence, treatment with &lt; Tramal retard &gt; should only be carried out for short periods under strict medical supervision.</p><p>&nbsp;</p><p>When a patient no longer requires therapy with tramadol, it may be advisable to taper the dose gradually to prevent symptoms of withdrawal.</p><p>&nbsp;</p><p>Tramadol is not suitable as a substitute in opioid-dependent patients. Although it is an opioid agonist, tramadol cannot suppress morphine withdrawal symptoms.</p><p>&nbsp;</p><p>&lt; Tramal retard &gt; prolonged-release tablets contain lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption, should not take this medicinal product.</p><p>CYP2D6 metabolism</p><p>Tramadol is metabolised by the liver enzyme CYP2D6. If a patient has a deficiency or is completely lacking this enzyme an adequate analgesic effect may not be obtained. Estimates indicate that up to 7% of the Caucasian population may have this deficiency. However, if the patient is an ultra-rapid metaboliser there is a risk of developing side effects of opioid toxicity even at commonly prescribed doses.</p><p>General symptoms of opioid toxicity include confusion, somnolence, shallow breathing, small pupils, nausea, vomiting, constipation and lack of appetite. In severe cases this may include symptoms of circulatory and respiratory depression, which may be life threatening and very rarely fatal. Estimates of prevalence of ultra-rapid metabolisers in different populations are summarised below:</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Population</p></td><td style="vertical-align:top"><p>Prevalence %</p></td></tr><tr><td style="vertical-align:top"><p>African/Ethiopian</p></td><td style="vertical-align:top"><p>29%</p></td></tr><tr><td style="vertical-align:top"><p>African American</p></td><td style="vertical-align:top"><p>3.4% to 6.5%</p></td></tr><tr><td style="vertical-align:top"><p>Asian</p></td><td style="vertical-align:top"><p>1.2% to 2%</p></td></tr><tr><td style="vertical-align:top"><p>Caucasian</p></td><td style="vertical-align:top"><p>3.6% to 6.5%</p></td></tr><tr><td style="vertical-align:top"><p>Greek</p></td><td style="vertical-align:top"><p>6.0%</p></td></tr><tr><td style="vertical-align:top"><p>Hungarian</p></td><td style="vertical-align:top"><p>1.9%</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>Northern European&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1% to 2%</p><p>&nbsp;</p><p>Post-operative use in children</p><p>There have been reports in the published literature that tramadol given post-operatively in children after tonsillectomy and/or adenoidectomy for obstructive sleep apnoea, led to rare, but life threatening adverse events. Extreme caution should be exercised when tramadol is administered to children for post-operative pain relief and should be accompanied by close monitoring for symptoms of opioid toxicity including respiratory depression.</p><p>&nbsp;</p><p>Children with compromised respiratory function</p><p>Tramadol is not recommended for use in children in whom respiratory function might be compromised including neuromuscular disorders, severe cardiac or respiratory conditions, upper respiratory or lung infections, multiple trauma or extensive surgical procedures. These factors may worsen symptoms of opioid toxicity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&lt; Tramal retard &gt; should not be combined with MAO inhibitors (see section 4.3).</p><p>&nbsp;</p><p>In patients treated with MAO inhibitors in the 14 days prior to the use of the opioid pethidine, life- threatening interactions on the central nervous system, respiratory and cardiovascular function have been observed. The same interactions with MAO inhibitors cannot be ruled out during treatment with</p><p>&lt; Tramal retard &gt;.</p><p>&nbsp;</p><p>Concomitant administration of &lt; Tramal retard &gt; with other centrally depressant medicinal products including alcohol may potentiate the CNS effects (see section 4.8).</p><p>&nbsp;</p><p>The results of pharmacokinetic studies have so far shown that on the concomitant or previous administration of cimetidine (enzyme inhibitor) clinically relevant interactions are unlikely to occur. Simultaneous or previous administration of carbamazepine (enzyme inducer) may reduce the analgesic effect and shorten the duration of action.</p><p>&nbsp;</p><p>Tramadol can induce convulsions and increase the potential for selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, antipsychotics and other seizure threshold-lowering medicinal products (such as bupropion, mirtazapine, tetrahydrocannabinol) to cause convulsions.</p><p>&nbsp;</p><p>Concomitant therapeutic use of tramadol and serotonergic drugs such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), MAO inhibitors (see section 4.3), tricyclic antidepressants and mirtazapine may cause serotonin toxicity. Serotonin syndrome is likely when one of the following is observed:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Spontaneous clonus</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inducible or ocular clonus with agitation or diaphoresis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tremor and hyperreflexia</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypertonia and body temperature &gt;38&deg;C and inducible or ocular clonus.</p><p>Withdrawal of the serotonergic drugs usually brings about a rapid improvement. Treatment depends on the type and severity of the symptoms.</p><p>&nbsp;</p><p>Caution should be exercised during concomitant treatment with tramadol and coumarin derivatives (e.g. warfarin) due to reports of increased INR with major bleeding and ecchymoses in some patients.</p><p>&nbsp;</p><p>&nbsp;</p><p>Other active substances known to inhibit CYP3A4, such as ketoconazole and erythromycin, might inhibit the metabolism of tramadol (N-demethylation) probably also the metabolism of the active O- demethylated metabolite. The clinical importance of such an interaction has not been studied (see section 4.8).</p><p>&nbsp;</p><p>In a limited number of studies the pre- or postoperative application of the antiemetic 5-HT3 antagonist ondansetron increased the requirement of tramadol in patients with postoperative pain.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>&nbsp;</p><p>Animal studies with tramadol revealed at very high doses effects on organ development, ossification and neonatal mortality. Teratogenic effects were not observed. Tramadol crosses the placenta. There is inadequate evidence available on the safety of tramadol in human pregnancy. Therefore</p><p>&lt; Tramal retard &gt; should not be used in pregnant women.</p><p>Tramadol - administered before or during birth - does not affect uterine contractility. In neonates it may induce changes in the respiratory rate which are usually not clinically relevant. Chronic use during pregnancy may lead to neonatal withdrawal symptoms.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>&nbsp;</p><p>Approximately 0.1% of the maternal dose of tramadol is excreted in breast milk. In the immediate</p><p>post-partum period, for maternal oral daily dosage up to 400 mg, this corresponds to a mean amount of tramadol ingested by breast-fed infants of 3% of the maternal weight-adjusted dosage. For this reason tramadol should not be used during lactation or alternatively, breast-feeding should be discontinued during treatment with tramadol. Discontinuation of breast-feeding is generally not necessary following a single dose of tramadol.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>&nbsp;</p><p>Post marketing surveillance does not suggest an effect of tramadol on fertility. Animal studies did not show an effect of tramadol on fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Even when taken according to instructions, &lt; Tramal retard &gt; may cause effects such as somnolence and dizziness and therefore may impair the reactions of drivers and machine operators. This applies particularly in conjunction with alcohol and other psychotropic substances.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported adverse reactions are nausea and dizziness, both occurring in more than 10 % of patients.</p><p>&nbsp;</p><p>The frequencies are defined as follows: Very common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/10</p><p>Common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/100 to &lt;1/10</p><p>Uncommon:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/1000 to &lt;1/100</p><p>Rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/10 000 to &lt;1/1000</p><p>Very rare:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &lt;1/10 000</p><p>Not known:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; frequency cannot be estimated from the available data</p><p>&nbsp;</p><p><em>Immune system disorders</em></p><p>Rare: allergic reactions (e.g. dyspnoea, bronchospasm, wheezing, angioneurotic oedema) and anaphylaxis</p><p>&nbsp;</p><p><em>Cardiac</em><em> </em><em>disorders</em></p><p>Uncommon: cardiovascular regulation (palpitation, tachycardia). These adverse reactions may occur especially on intravenous administration and in patients who are physically stressed.</p><p>Rare: bradycardia</p><p>&nbsp;</p><p><em>Investigations</em></p><p>Rare: increase in blood pressure</p><p>&nbsp;</p><p><em>Vascular disorders</em></p><p>Uncommon: cardiovascular regulation (postural hypotension or cardiovascular collapse). These adverse reactions may occur especially on intravenous administration and in patients who are physically stressed.</p><p>&nbsp;</p><p><em>Nervous system disorders</em></p><p>Very common: dizziness Common: headache, somnolence</p><p>Rare: paraesthesia, tremor, convulsions, muscle contractions involuntary, coordination abnormal, syncope, speech disorders.</p><p>Convulsion occurred mainly after administration of high doses of tramadol or after concomitant treatment with medicinal products which can lower the seizure threshold (see section 4.4 and 4.5).</p><p>&nbsp;</p><p><em>Metabolism and nutrition disorders</em></p><p>Rare: changes in appetite Not known: hypoglycaemia</p><p>&nbsp;</p><p><em>Psychiatric</em><em> </em><em>disorders</em></p><p>Rare: hallucination, confusional state, sleep disturbance, delirium, anxiety and nightmares. Psychic adverse reactions may occur following administration of &lt; Tramal retard &gt; which vary individually in intensity and nature (depending on personality and duration of treatment). These include changes in mood (usually euphoric mood, occasionally dysphoria), changes in activity (usually suppression, occasionally increase) and changes in cognitive and sensorial capacity (e.g. decision behaviour, perception disorders). Drug dependence may occur. Symptoms of drug withdrawal syndrome, similar to those occurring during opiate withdrawal, may occur as follows: agitation, anxiety, nervousness, insomnia, hyperkinesia, tremor and gastrointestinal symptoms. Other symptoms that have very rarely been seen with tramadol discontinuation include: panic attacks, severe anxiety, hallucination, paraesthesias, tinnitus and unusual CNS symptoms (i.e. confusional state, delusions, depersonalization, derealization, paranoia).</p><p>&nbsp;</p><p><em>Eye disorders</em></p><p>Rare: miosis, vision blurred, mydriasis</p><p>&nbsp;</p><p><em>Respiratory,</em><em> </em><em>thoracic and mediastinal disorders</em></p><p>Rare: respiratory depression, dyspnoea.</p><p>If the recommended doses are considerably exceeded and other centrally depressant substances are administered concomitantly (see section 4.5), respiratory depression may occur.</p><p>Worsening of asthma has been reported, though a causal relationship has not been established.</p><p>&nbsp;</p><p><em>Gastrointestinal</em><em> </em><em>disorders</em></p><p>Very common: nausea</p><p>Common: constipation, dry mouth, vomiting</p><p>Uncommon: retching, gastrointestinal discomfort (a feeling of pressure in the stomach, bloating), diarrhoea</p><p>&nbsp;</p><p><em>Skin</em><em> </em><em>and</em><em> </em><em>subcutaneous</em><em> </em><em>tissue disorders</em></p><p>Common: hyperhidrosis</p><p>Uncommon: dermal reactions (e.g. pruritus, rash, urticaria)</p><p>&nbsp;</p><p><em>Musculoskeletal</em><em> </em><em>disorders</em></p><p>Rare: motorial weakness</p><p>&nbsp;</p><p><em>Hepatobiliary</em><em> </em><em>disorders</em></p><p>In a few isolated cases hepatic enzyme increased has been reported in a temporal connection with the therapeutic use of tramadol.</p><p><em>Renal</em><em> </em><em>and</em><em> </em><em>urinary</em><em> </em><em>disorders</em></p><p>Rare: micturition disorder (dysuria and urinary retention)</p><p>&nbsp;</p><p><em>General disorders</em></p><p>Common: fatigue</p><p><em>Reporting of suspected adverse reactions</em></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via &lt;[to be completed nationally]&gt;.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Symptoms</em></p><p><em>&nbsp;</em></p><p>In principle, on intoxication with tramadol symptoms similar to those of other centrally acting analgesics (opioids) are to be expected. These include in particular miosis, vomiting, cardiovascular collapse, consciousness disorders up to coma, convulsions and respiratory depression up to respiratory arrest.</p><p>&nbsp;</p><p><em>Treatment</em></p><p><em>&nbsp;</em></p><p>The general emergency measures apply. Keep open the respiratory tract (aspiration!), maintain respiration and circulation depending on the symptoms.</p><p>&nbsp;</p><p>The antidote for respiratory depression is naloxone. In animal experiments naloxone had no effect on convulsions. In such cases diazepam should be given intravenously.</p><p>&nbsp;</p><p>In case of intoxication with oral formulations, gastrointestinal decontamination with activated charcoal or by gastric lavage is only recommended within 2 hours after tramadol intake. Gastrointestinal decontamination at a later time point may be useful in case of intoxication with exceptionally large quantities or prolonged-release formulations.</p><p>&nbsp;</p><p>Tramadol is minimally eliminated from the serum by haemodialysis or haemofiltration. Therefore treatment of acute intoxication with &lt; Tramal retard &gt; with haemodialysis or haemofiltration alone is not suitable for detoxification.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: other opioids; ATC code: N 02 AX02</p><p>&nbsp;</p><p>Tramadol is a centrally-acting opioid analgesic. It is a non-selective pure agonist at &micro;, &delta; and &kappa; opioid receptors with a higher affinity for the &micro; receptor. Other mechanisms which contribute to its analgesic effect are inhibition of neuronal re-uptake of noradrenaline and enhancement of serotonin release.</p><p>&nbsp;</p><p>Tramadol has an antitussive effect. In contrast to morphine, analgesic doses of tramadol over a wide range have no respiratory-depressant effect. Also gastrointestinal motility is less affected. Effects on the cardiovascular system tend to be slight. The potency of tramadol is reported to be 1/10 (one tenth) to 1/6 (one sixth) that of morphine.</p><p>&nbsp;</p><p><u>Paediatric population</u></p><p>&nbsp;</p><p>Effects of enteral and parenteral administration of tramadol have been investigated in clinical trials involving more than 2000 paediatric patients ranging in age from neonate to 17 years of age. The indications for pain treatment studied in those trials included pain after surgery (mainly abdominal), after surgical tooth extractions, due to fractures, burns and traumas as well as other painful conditions likely to require analgesic treatment for at least 7 days.</p><p>&nbsp;</p><p>At single doses of up to 2 mg/kg or multiple doses of up to 8 mg/kg per day (to a maximum of 400 mg per day) efficacy of tramadol was found to be superior to placebo, and superior or equal to paracetamol, nalbuphine, pethidine or low dose morphine. The conducted trials confirmed the efficacy of tramadol. The safety profile of tramadol was similar in adult and paediatric patients older than 1 year (see section 4.2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>More than 90% of &lt; Tramal retard &gt; is absorbed after oral administration. The mean absolute bioavailability is approximately 70 %, irrespective of the concomitant intake of food. The difference between absorbed and non-metabolised available tramadol is probably due to the low first-pass effect. The first-pass effect after oral administration is a maximum of 30 %.</p><p>&nbsp;</p><p>Tramadol has a high tissue affinity (Vd,&szlig; = 203 &plusmn; 40 l). It has a plasma protein binding of about 20 %.</p><p>&nbsp;</p><p>After administration of &lt; Tramal retard &gt; 100 mg the peak plasma concentration</p><p>Cmax = 141 &plusmn; 40 ng/ml is reached after 4.9 h; after administration of &lt; Tramal retard &gt; 200 mg Cmax 260 &plusmn; 62 ng/ml is reached after 4.8 hours.</p><p>&nbsp;</p><p>Tramadol passes the blood-brain and placental barriers. Very small amounts of the substance and its O-desmethyl derivative are found in the breast-milk (0.1 % and 0.02 % respectively of the applied dose).</p><p>&nbsp;</p><p>Elimination&nbsp;half-life t1/2,&szlig; is approximately 6 h, irrespective of the mode of administration. In patients above 75 years of age it may be prolonged by a factor of approximately 1.4.</p><p>&nbsp;</p><p>In humans tramadol is mainly metabolised by means of N- and O-demethylation and conjugation of the O-demethylation products with glucuronic acid. Only O-desmethyltramadol is pharmacologically active. There are considerable interindividual quantitative differences between the other metabolites. So far, eleven metabolites have been found in the urine. Animal experiments have shown that O- desmethyltramadol is more potent than the parent substance by the factor 2 - 4. Its half-life t1/2,&szlig; (6 healthy volunteers) is 7.9 h (range 5.4 - 9.6 h) and is approximately that of tramadol.</p><p>&nbsp;</p><p>The inhibition of one or both types of the isoenzymes CYP3A4 and CYP2D6 involved in the biotransformation of tramadol may affect the plasma concentration of tramadol or its active metabolite.</p><p>&nbsp;</p><p>Tramadol and its metabolites are almost completely excreted via the kidneys. Cumulative urinary excretion is 90 % of the total radioactivity of the administered dose. In case of impaired hepatic or renal function the half-life may be slightly prolonged. In patients with cirrhosis of the liver, elimination half-lives of 13.3 &plusmn; 4.9 h (tramadol) and 18.5 &plusmn; 9.4 h (O-desmethyltramadol), in an extreme case 22.3 h and 36 h respectively, have been determined. In patients with renal insufficiency (creatinine clearance &lt; 5 ml/min) the values were 11 &plusmn; 3.2 h and 16.9 &plusmn; 3 h, in an extreme case 19.5 h and 43.2 h respectively.</p><p>&nbsp;</p><p>Tramadol has a linear pharmacokinetic profile within the therapeutic dosage range.</p><p>&nbsp;</p><p>The relationship between serum concentrations and the analgesic effect is dose-dependent, but varies considerably in isolated cases. A serum concentration of 100 &ndash; 300 ng/ml is usually effective.</p><p>&nbsp;</p><p><u>Paediatric population</u></p><p>&nbsp;</p><p>The pharmacokinetics of tramadol and O-desmethyltramadol after single-dose and multiple-dose oral administration to subjects aged 1 year to 16 years were found to be generally similar to those in adults when adjusting for dose by body weight, but with a higher between-subject variability in children aged 8 years and below.</p><p>&nbsp;</p><p>In children below 1 year of age, the pharmacokinetics of tramadol and O-desmethyltramadol have been investigated, but have not been fully characterized. Information from studies including this age group indicates that the formation rate of O-desmethyltramadol via CYP2D6 increases continuously in neonates, and adult levels of CYP2D6 activity are assumed to be reached at about 1 year of age. In addition, immature glucuronidation systems and immature renal function may result in slow elimination and accumulation of O-desmethyltramadol in children under 1 year of age.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>On repeated oral and parenteral administration of tramadol for 6 - 26 weeks in rats and dogs and oral administration for 12 months in dogs haematological, clinico-chemical and histological investigations showed no evidence of any substance-related changes. Central nervous manifestations only occurred after high doses considerably above the therapeutic range: restlessness, salivation, convulsions, and reduced weight gain. Rats and dogs tolerated oral doses of 20 mg/kg and 10 mg/kg body weight respectively, and dogs rectal doses of 20 mg/kg body weight without any reactions.</p><p>&nbsp;</p><p>In rats tramadol dosages from 50 mg/kg/day upwards caused toxic effects in dams and raised neonate mortality. In the offspring retardation occurred in the form of ossification disorders and delayed vaginal and eye opening. Male and female fertility was not affected. In rabbits there were toxic effects in dams from 125 mg/kg upwards and skeletal anomalies in the offspring.</p><p>&nbsp;</p><p>In some in-vitro test systems there was evidence of mutagenic effects. In-vivo studies showed no such effects. According to knowledge gained so far, tramadol can be classified as non-mutagenic.</p><p>&nbsp;</p><p>Studies on the tumorigenic potential of tramadol hydrochloride have been carried out in rats and mice. The study in rats showed no evidence of any substance-related increase in the incidence of tumours. In</p><p>&nbsp;</p><p>the study in mice there was an increased incidence of liver cell adenomas in male animals (a dose- dependent, non-significant increase from 15 mg/kg upwards) and an increase in pulmonary tumours in females of all dosage groups (significant, but not dose-dependent).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&lt; Tramal retard &gt; 50 mg, prolonged-release tablets Tablet core:</p><p>-&nbsp; microcrystalline cellulose</p><p>-&nbsp; hypromellose 100 000 mPa&middot;s</p><p>-&nbsp; magnesium stearate</p><p>-&nbsp; colloidal anhydrous silica.</p><p>Film coating:</p><p>-&nbsp; hypromellose 6 mPa&middot;s</p><p>-&nbsp; lactose monohydrate</p><p>-&nbsp; macrogol 6000</p><p>-&nbsp; propylene glycol</p><p>-&nbsp; talc</p><p>-&nbsp; titanium dioxide (E 171)</p><p>-&nbsp; yellow iron oxide (E 172)</p><p>&nbsp;</p><p>&lt; Tramal retard &gt; 100 mg, prolonged-release tablets Tablet core:</p><p>-&nbsp; microcrystalline cellulose</p><p>-&nbsp; hypromellose 100 000 mPa&middot;s</p><p>-&nbsp; magnesium stearate</p><p>-&nbsp; colloidal anhydrous silica Film coating:</p><p>-&nbsp; hypromellose 6 mPa&middot;s</p><p>-&nbsp; lactose monohydrate</p><p>-&nbsp; macrogol 6000</p><p>-&nbsp; propylene glycol</p><p>-&nbsp; talc</p><p>-&nbsp; titanium dioxide (E 171)</p><p>&nbsp;</p><p>&lt; Tramal retard &gt; 150 mg, prolonged-release tablets Tablet core:</p><p>-&nbsp; microcrystalline cellulose</p><p>-&nbsp; hypromellose 100 000 mPa&middot;s</p><p>-&nbsp; magnesium stearate</p><p>-&nbsp; colloidal anhydrous silica Film coating:</p><p>-&nbsp; hypromellose 6 mPa&middot;s</p><p>-&nbsp; lactose monohydrate</p><p>-&nbsp; macrogol 6000</p><p>-&nbsp; propylene glycol</p><p>-&nbsp; talc</p><p>-&nbsp; titanium dioxide (E 171)</p><p>-&nbsp; quinoline yellow lake (E 104)</p><p>-&nbsp; red iron oxide (E 172)</p><p>&nbsp;</p><p>&lt; Tramal retard &gt; 200 mg, prolonged-release tablets Tablet core:</p><p>&nbsp;</p><p>-&nbsp; microcrystalline cellulose</p><p>-&nbsp; hypromellose 100 000 mPa&middot;s</p><p>-&nbsp; magnesium stearate</p><p>-&nbsp; colloidal anhydrous silica Film coating:</p><p>-&nbsp; hypromellose 6 mPa&middot;s</p><p>-&nbsp; lactose monohydrate</p><p>-&nbsp; macrogol 6000</p><p>-&nbsp; propylene glycol</p><p>-&nbsp; talc</p><p>-&nbsp; titanium dioxide (E 171)</p><p>-&nbsp; quinoline yellow lake (E 104)</p><p>-&nbsp; red iron oxide (E 172)</p><p>-&nbsp; brown iron oxide (E 172)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                4 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aluminium/Polypropylene or Aluminium/PVC/PVDC foil blisters.</p><p>Pack sizes of 10, 20, 30, 50, 60, 100, 150 (10x15) prolonged-release tablets. Not all pack sizes may be marketed</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements for disposal.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
STADA Arzneimittel AG Stadastrasse 2-18
61118 Bad Vilbel Germany

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                March 2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>